Patents-Review.com
ClassID:

96556 ⎘

C07J41/0094 - CPC Classification

Classification description:

Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by containing nitrile radicals, including thiocyanide radicals

Recent Application in this class:
#1
20260055110
2026-02-26

COMPOUNDS AND METHODS FOR THE TREATMENT OF DERMAL AND OCULAR DISORDERS

 #2
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #3
20250376488
2025-12-11

FARNESOID X RECEPTOR MODULATORS

 #4
20250296951
2025-09-25

GPX4 Inhibitors and Senolytic Compounds and Uses Thereof

 #5
20250154194
2025-05-15

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #6
20250092084
2025-03-20

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #7
20250051387
2025-02-13

STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF

 #8
20240368214
2024-11-07

POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

 #9
20240368212
2024-11-07

SELECTIVE ISONITRILE INHIBITORS OF CYTOCHROME P450 SUBTYPES

 #10
20240343756
2024-10-17

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #11
20240336648
2024-10-10

Neuroactive steroids and their methods of use

 #12
20240309042
2024-09-19

Neuroactive steroids and their methods of use

 #13
20240239835
2024-07-18

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #14
20240140984
2024-05-02

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #15
20240124515
2024-04-18

ORALLY ACTIVE LEUKEMIA INHIBITORY FACTOR (LIF) ANTAGONISTS FOR THE TREATMENT OF CANCER

 #16
20230322849
2023-10-12

Neuroactive steroids and their methods of use

 #17
20230322848
2023-10-12

Neuroactive steroids and their methods of use

 #18
20230322847
2023-10-12

Neuroactive steroids and their methods of use

 #19
20230322846
2023-10-12

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #20
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #21
20230183288
2023-06-15

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #22
20230116347
2023-04-13

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #23
20230066156
2023-03-02

6-SUBSTITUTED, 22-CYANO HYODEOXYCHOLANIC ANALOGUES AND USES THEREOF

 #24
20230046825
2023-02-16

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #25
20230021308
2023-01-19

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #26
20220204548
2022-06-30

SMALL MOLECULE MODULATORS OF GUT BACTERIAL BILE ACID METABOLISM

 #27
20220169672
2022-06-02

COMPOUNDS FOR TARGETED THERAPIES OF CASTRATION RESISTANT PROSTATE CANCER

 #28
20220017565
2022-01-20

Steroid derivative regulators, method for preparing the same, and uses thereof

 #29
20220002340
2022-01-06

C7, C12, and C16 substituted neuroactive steroids and their methods of use

 #30
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #31
20210269475
2021-09-02

Farnesoid X receptor modulators

 #32
20210261600
2021-08-26

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #33
20210230211
2021-07-29

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #34
20210188897
2021-06-24

NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF

 #35
20210179661
2021-06-17

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #36
20210139530
2021-05-13

Steroid derivative regulators, method for preparing the same, and uses thereof

 #37
20200347092
2020-11-05

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #38
20200262863
2020-08-20

PREPARATION OF DEOXYCHOLIC ACID

 #39
20200165136
2020-05-28

Scroll composite having amphiphilic substance inside and method for preparation of the same

 #40
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #41
20200017542
2020-01-16

Neuroactive steroids, compositions, and uses thereof

 #42
20190352328
2019-11-21

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

 #43
20190309012
2019-10-10

Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

 #44
20190284227
2019-09-19

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #45
20190248831
2019-08-15

C17, C20, and C21 substituted neuroactive steroids and their methods of use

 #46
20190233465
2019-08-01

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #47
20190202857
2019-07-04

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #48
20190194245
2019-06-27

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #49
20190085019
2019-03-21

Raman tag

 #50
20180243426
2018-08-30

Compounds and methods for trans-membrane delivery of molecules

 #51
20180237383
2018-08-23

NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE

 #52
20180215779
2018-08-02

Neuroactive steroids, compositions, and uses thereof

 #53
20180155386
2018-06-07

PROGESTERONE ANTAGONISTS

 #54
20180148470
2018-05-31

CHOLIC ACID DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF

 #55
20170334944
2017-11-23

Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #56
20170313738
2017-11-02

Raman tag

 #57
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #58
20170190731
2017-07-06

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

 #59
20170152284
2017-06-01

NEUROACTIVE 19-ALKOXY-17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #60
20170152282
2017-06-01

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #61
20170101434
2017-04-13

Farnesoid X receptor modulators

 #62
20160355401
2016-12-08

Scroll composite having amphiphilic substance inside and method for preparation of the same

 #63
20160310398
2016-10-27

Sunscreen molecule and compositions thereof

 #64
20160297848
2016-10-13

Process for the production of 19-norpregn-4-en-3,20-dione-17α-ol(gestonorone) and intermediates therefor

 #65
20160251391
2016-09-01

Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors

 #66
20160185815
2016-06-30

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #67
20160152658
2016-06-02

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #68
20160145296
2016-05-26

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

 #69
20160145295
2016-05-26

Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof

 #70
20160145200
2016-05-26

Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use

 #71
20160129125
2016-05-12

Compounds and methods for trans-membrane delivery of molecules

 #72
20160120996
2016-05-05

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

 #73
20160106855
2016-04-21

Compounds and methods for trans-membrane delivery of molecules

 #74
20160096864
2016-04-07

Cationic steroidal antimicrobial prodrug compositions and uses thereof

 #75
20160068562
2016-03-10

Raman tag

 #76
20150284423
2015-10-08

3-(4′-substituted)-benzyl-ether derivatives of pregnenolone

 #77
20150259376
2015-09-17

Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #78
20150175651
2015-06-25

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #79
20140309443
2014-10-16

Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

 #80
20140296510
2014-10-02

Method for preparing ulipristal acetate and key intermediate thereof

 #81
20140235600
2014-08-21

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #82
20130041166
2013-02-14

PROCESS FOR THE PREPARATION OF DIENOGEST SUBSTANTIALLY FREE OF IMPURITIES

 #83
20130029953
2013-01-31

PROGESTERONE ANTAGONISTS

 #84
20120316145
2012-12-13

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases

 #85
20120283450
2012-11-08

Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use

 #86
20120283217
2012-11-08

MODULATORS OF AMYLOID-BETA PRODUCTION

 #87
20120258941
2012-10-11

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases

 #88
20120190660
2012-07-26

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases

 #89
20120184515
2012-07-19

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases

 #90
20110245196
2011-10-06

Sulfated oligosaccharide derivatives

 #91
20110091376
2011-04-21

Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods

 #92
20100303758
2010-12-02

Novel Glucocorticoid Receptor Agonists

 #93
20100298585
2010-11-25

METHOD FOR SYNTHESIS OF DIENOGEST FROM ESTRONE-3-METHYLETHER

 #94
20100292184
2010-11-18

17BETA-CYANO-19-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE

 #95
20100261896
2010-10-14

Methods for the preparation of drospirenone

 #96
20100137622
2010-06-03

Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process

 #97
20100113408
2010-05-06

21-substituted progesterone derivatives as new antiprogestational agents

 #98
20100056487
2010-03-04

MODULATORS OF AMYLOID-BETA PRODUCTION

 #99
20100048887
2010-02-25

Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use

 #100
20090124588
2009-05-14

Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions

 #101
20090048218
2009-02-19

17Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE

 #102
20090048217
2009-02-19

17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative

 #103
20090042844
2009-02-12

17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators

 #104
20080287404
2008-11-20

High purity 17α-cyanomethyl-17β-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof

 #105
20080182831
2008-07-31

Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions

 #106
20080027237
2008-01-31

Processes for preparations of 9,11-epoxy steroids and intermediates useful therein

 #107
20070099880
2007-05-03

Estrogen receptor modulators

 #108
20060276443
2006-12-07

21-substituted progesterone derivatives as new antiprogestational agents

 #109
20060258857
2006-11-16

Process for making steroidal compounds

 #110
20050256094
2005-11-17

Processes for preparation of 9,11-epoxy steroids and intermediates useful therein

 #111
20050159594
2005-07-21

Eplerenone crystal form exhibiting enhanced dissolution rate

 #112
20050143365
2005-06-30

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

 #113
20050143364
2005-06-30

21-substituted progesterone derivatives as new antiprogestational agents

 #114
20050101573
2005-05-12

Meiosis regulating compounds

 #115
20050080060
2005-04-14

Antigestagenically active steroids with a fluorinated 17α-alkyl chain